Selecting COVID-19 Convalescent Plasma for Neutralizing Antibody Potency Using a High-capacity SARS-CoV-2 Antibody Assay
E Goodhue Meyer, G Simmons, E Grebe, M Gannett, S Franz, O Darst, C Di Germanio, M Stone, P Contestable, A Prichard, R Reik, R Vassallo, P Young, MP Busch, P Williamson, LJ Dumont
doi: https://doi.org/10.1101/2020.08.31.20184895
E Goodhue Meyer
1Medical Office, Biomedical Services, American Red Cross
2Nationwide Children’s Hospital, Columbus, OH
G Simmons
3Vitalant Research Institute, San Francisco, CA
E Grebe
3Vitalant Research Institute, San Francisco, CA
4University of California, San Francisco, San Francisco, CA
M Gannett
5OneBlood, St. Petersburg, FL
S Franz
3Vitalant Research Institute, San Francisco, CA
O Darst
3Vitalant Research Institute, San Francisco, CA
C Di Germanio
3Vitalant Research Institute, San Francisco, CA
M Stone
3Vitalant Research Institute, San Francisco, CA
P Contestable
6Ortho Clinical Diagnostics, Rochester, NY
A Prichard
5OneBlood, St. Petersburg, FL
R Reik
5OneBlood, St. Petersburg, FL
R Vassallo
7Vitalant, Scottsdale, AZ
8University of New Mexico School of Medicine, Albuquerque, NM
P Young
1Medical Office, Biomedical Services, American Red Cross
9Vanderbilt School of Medicine, Nashville, TN
MP Busch
3Vitalant Research Institute, San Francisco, CA
4University of California, San Francisco, San Francisco, CA
P Williamson
10Creative Testing Solutions, Tempe, AZ
LJ Dumont
11Vitalant Research Institute, Denver, CO
12Geisel School of Medicine at Dartmouth, Lebanon, NH
13University of Colorado School of Medicine, Aurora, CO
Article usage
Posted September 02, 2020.
Selecting COVID-19 Convalescent Plasma for Neutralizing Antibody Potency Using a High-capacity SARS-CoV-2 Antibody Assay
E Goodhue Meyer, G Simmons, E Grebe, M Gannett, S Franz, O Darst, C Di Germanio, M Stone, P Contestable, A Prichard, R Reik, R Vassallo, P Young, MP Busch, P Williamson, LJ Dumont
medRxiv 2020.08.31.20184895; doi: https://doi.org/10.1101/2020.08.31.20184895
Selecting COVID-19 Convalescent Plasma for Neutralizing Antibody Potency Using a High-capacity SARS-CoV-2 Antibody Assay
E Goodhue Meyer, G Simmons, E Grebe, M Gannett, S Franz, O Darst, C Di Germanio, M Stone, P Contestable, A Prichard, R Reik, R Vassallo, P Young, MP Busch, P Williamson, LJ Dumont
medRxiv 2020.08.31.20184895; doi: https://doi.org/10.1101/2020.08.31.20184895
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2296)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11621)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3625)
- Geriatric Medicine (340)
- Health Economics (622)
- Health Informatics (2330)
- Health Policy (918)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (393)
- Neurology (3389)
- Nursing (193)
- Nutrition (512)
- Oncology (1776)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1012)
- Primary Care Research (409)
- Public and Global Health (6020)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)